Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.814 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.8077 |
Intermediate Similarity |
NPD7236 |
Approved |
0.8059 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.8046 |
Intermediate Similarity |
NPD8361 |
Approved |
0.8046 |
Intermediate Similarity |
NPD8435 |
Approved |
0.8046 |
Intermediate Similarity |
NPD8360 |
Approved |
0.8036 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7978 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7937 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7919 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7845 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7753 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7458 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7458 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7394 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7394 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7283 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7257 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7249 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7135 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7135 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD7874 |
Approved |
0.711 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.709 |
Intermediate Similarity |
NPD6780 |
Approved |
0.709 |
Intermediate Similarity |
NPD6782 |
Approved |
0.709 |
Intermediate Similarity |
NPD6781 |
Approved |
0.709 |
Intermediate Similarity |
NPD6779 |
Approved |
0.709 |
Intermediate Similarity |
NPD6778 |
Approved |
0.709 |
Intermediate Similarity |
NPD6777 |
Approved |
0.709 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7086 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7079 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7076 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7068 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7068 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7041 |
Intermediate Similarity |
NPD8462 |
Phase 1 |
0.7035 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7022 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7017 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.701 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD7801 |
Approved |
0.6974 |
Remote Similarity |
NPD8151 |
Discontinued |
0.697 |
Remote Similarity |
NPD7003 |
Approved |
0.6964 |
Remote Similarity |
NPD6273 |
Approved |
0.6961 |
Remote Similarity |
NPD6764 |
Approved |
0.6961 |
Remote Similarity |
NPD6765 |
Approved |
0.6961 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6959 |
Remote Similarity |
NPD7411 |
Suspended |
0.6954 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6941 |
Remote Similarity |
NPD3226 |
Approved |
0.6932 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6923 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.689 |
Remote Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD7054 |
Approved |
0.6879 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD5494 |
Approved |
0.6868 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6868 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6851 |
Remote Similarity |
NPD7472 |
Approved |
0.6847 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6842 |
Remote Similarity |
NPD7741 |
Discontinued |
0.6833 |
Remote Similarity |
NPD7228 |
Approved |
0.6833 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6821 |
Remote Similarity |
NPD1934 |
Approved |
0.6821 |
Remote Similarity |
NPD37 |
Approved |
0.6813 |
Remote Similarity |
NPD3764 |
Approved |
0.6811 |
Remote Similarity |
NPD6784 |
Approved |
0.6811 |
Remote Similarity |
NPD6785 |
Approved |
0.6807 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6804 |
Remote Similarity |
NPD7497 |
Discontinued |
0.68 |
Remote Similarity |
NPD3882 |
Suspended |
0.68 |
Remote Similarity |
NPD5951 |
Approved |
0.68 |
Remote Similarity |
NPD4965 |
Approved |
0.68 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.68 |
Remote Similarity |
NPD4966 |
Approved |
0.6788 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6772 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6772 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6753 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6753 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6735 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD5404 |
Approved |
0.6727 |
Remote Similarity |
NPD5405 |
Approved |
0.6727 |
Remote Similarity |
NPD5406 |
Approved |
0.6727 |
Remote Similarity |
NPD5408 |
Approved |
0.6723 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6706 |
Remote Similarity |
NPD2533 |
Approved |
0.6706 |
Remote Similarity |
NPD2534 |
Approved |
0.6706 |
Remote Similarity |
NPD2532 |
Approved |
0.6687 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6686 |
Remote Similarity |
NPD2801 |
Approved |
0.6685 |
Remote Similarity |
NPD7240 |
Approved |
0.6667 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3749 |
Approved |
0.6667 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6647 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6645 |
Remote Similarity |
NPD5126 |
Approved |
0.6645 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6644 |
Remote Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.6629 |
Remote Similarity |
NPD919 |
Approved |
0.6628 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6627 |
Remote Similarity |
NPD2796 |
Approved |
0.6622 |
Remote Similarity |
NPD2182 |
Approved |
0.6606 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6605 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6603 |
Remote Similarity |
NPD8328 |
Phase 3 |
0.6598 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6591 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6587 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6587 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6585 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6579 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6575 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.657 |
Remote Similarity |
NPD1512 |
Approved |
0.6568 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6568 |
Remote Similarity |
NPD3750 |
Approved |
0.6567 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6567 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6566 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6566 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6561 |
Remote Similarity |
NPD6287 |
Discontinued |
0.6558 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6556 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6554 |
Remote Similarity |
NPD5345 |
Clinical (unspecified phase) |
0.6552 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6548 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6548 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6543 |
Remote Similarity |
NPD7095 |
Approved |
0.6533 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6532 |
Remote Similarity |
NPD920 |
Approved |
0.6531 |
Remote Similarity |
NPD5048 |
Discontinued |
0.6529 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6527 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6527 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6513 |
Remote Similarity |
NPD6010 |
Discontinued |
0.651 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6503 |
Remote Similarity |
NPD6798 |
Discontinued |
0.65 |
Remote Similarity |
NPD1470 |
Approved |
0.65 |
Remote Similarity |
NPD7319 |
Approved |
0.6497 |
Remote Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.6491 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.649 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6488
|
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |